Rocuronium
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Intraoperative Complications
Conditions
Intraoperative Complications, Postoperative Complications, Laparoscopy, Surgical Complications From General Anesthesia, Ventilator-Induced Lung Injury
Trial Timeline
Jan 1, 2014 → Oct 1, 2015
NCT ID
NCT02025075About Rocuronium
Rocuronium is a pre-clinical stage product being developed by Merck for Intraoperative Complications. The current trial status is completed. This product is registered under clinical trial identifier NCT02025075. Target conditions include Intraoperative Complications, Postoperative Complications, Laparoscopy.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02812186 | Approved | Completed |
| NCT02703909 | Approved | Completed |
| NCT02553629 | Approved | Completed |
| NCT02320734 | Approved | Completed |
| NCT02025075 | Pre-clinical | Completed |
| NCT00902070 | Pre-clinical | Completed |
Competing Products
3 competing products in Intraoperative Complications
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 77 |
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 77 |
| Floseal | Baxter | Approved | 82 |